ReviewContemporary clinical trials communications2019

Adaptive Signature Design- review of the biomarker guided adaptive phase -III controlled design.

Arinjita Bhattacharyya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.